To include your compound in the COVID-19 Resource Center, submit it here.

GenVec cancer, infectious news

GenVec's board adopted a new shareholder rights plan to replace the company's previous rights plan, which was set to expire

Read the full 200 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE